facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2021
vol. 108
 
Share:
Share:
abstract:
Case report

Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) caused by cotrimoxazole

Neelam Bhatt
1
,
Ravindranath B. Chavan
1
,
Nitika S. Deshmukh
1
,
Vasudha A. Belgaumkar
1

1.
B.J. Government Medical College, Pune, Maharashtra, India
Dermatol Rev/Przegl Dermatol 2021, 108, 67-73
Online publish date: 2021/05/13
View full text Get citation
 
PlumX metrics:
Introduction
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE or baboon syndrome) is an uncommon form of systemic contact dermatitis, readily differentiated from other drug eruptions by its peculiar appearance.

Case report
A 48-year-old male presented with itchy erythematous rash with blisters two days after taking an unknown drug. Dermatological examination revealed symmetrical erythematous macules with large bullae over the anterior trunk, neck, inner thighs and axillae. Systemic examination and laboratory parameters were normal. A diagnosis of symmetrical drug-related intertriginous and flexural exanthema associated with cotrimoxazole was made based on dermatological findings, histopathology and the reappearance of lesions after administration of cotrimoxazole (trimethoprim 160 mg and sulfamethoxazole 800 mg twice daily). Coincidentally, he was detected to be HIV seropositive and started a highly active antiretroviral therapy. His skin lesions resolved with systemic glucocorticosteroids.

Conclusions
Patients and clinicians should be aware of the possibility of a baboon syndrome due to cotrimoxazole, a widely used drug.

keywords:

symmetrical drug-related intertriginous and flexural exanthema, baboon syndrome, cotrimoxazole



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.